[Correspondence] Intravitreal aflibercept for proliferative diabetic retinopathy

We congratulate Sobha Sivaprasad and colleagues (June 3, p 2193)1 for their interesting paper on the clinical efficacy of intravitreal aflibercept versus panretinal laser photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy (the CLARITY study). The authors concluded that aflibercept was non-inferior and superior to panretinal laser photocoagulation in both the modified intention-to-treat population and the per-protocol population. These findings provide new, provocative data that should be taken into consideration when formulating a treatment management plan for individuals with proliferative diabetic retinopathy.
Source: LANCET - Category: General Medicine Authors: Tags: Correspondence Source Type: research